Consensus of Clinical Neurorestorative Progress in Patients with Complete Chronic Spinal Cord Injury

Hongyun Huang,Tiansheng Sun,Lin Chen,Gustavo Moviglia,Elena Chernykh,Klaus Von Wild,Haluk Deda,Kyung-Sun Kang,Anand Kumar,Sang Ryong Jeon,Shaocheng Zhang,Giorgio Brunelli,Albert Bohbot,Maria Dolors Soler,Jianjun Li,Alexandre Fogaça Cristante,Haitao Xi,Gelu Onose,Helmut Kern,Ugo Carraro,Hooshang Saberi,Hari Shanker Sharma,Alok Sharma,Xijing He,Dafin Muresanu,Shiqing Feng,Ali Otom,Dajue Wang,Koichi Iwatsu,Jike Lu,Adeeb Al-Zoubi
DOI: https://doi.org/10.3727/096368914x684952
2014-01-01
Cell Transplantation
Abstract:Currently, there is a lack of effective therapeutic methods to restore neurological function for chronic complete spinal cord injury (SCI) by conventional treatment. Neurorestorative strategies with positive preclinical results have been translated to the clinic, and some patients have gotten benefits and their quality of life has improved. These strategies include cell therapy, neurostimulation or neuromodulation, neuroprosthesis, neurotization or nerve bridging, and neurorehabilitation. The aim of this consensus by 31 experts from 20 countries is to show the objective evidence of clinical neurorestoration for chronic complete SCI by the mentioned neurorestorative strategies. Complete chronic SCI patients are no longer told, “nothing can be done.” The clinical translation of more effective preclinical neurorestorative strategies should be encouraged as fast as possible in order to benefit patients with incurable CNS diseases. This manuscript is published as part of the International Association of Neurorestoratology (IANR) special issue of Cell Transplantation.
What problem does this paper attempt to address?